Hand Function for Tetraplegia

Sponsor
VA Office of Research and Development (U.S. Fed)
Overall Status
Completed
CT.gov ID
NCT00890916
Collaborator
(none)
10
1
1
112
0.1

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the effectiveness of an implanted stimulator for providing hand function to individuals with cervical level spinal cord injury. The device stimulates the paralyzed muscles of the hand and forearm. The user of the device controls the stimulation by moving muscles that are not paralyzed, such as a wrist or neck muscle. The ability of the user to pick up and move objects, as well as perform various activities such as eating, drinking, and writing.

Condition or Disease Intervention/Treatment Phase
  • Device: FIRSTHAND System
N/A

Detailed Description

The overall object of this research is to provide restored functional abilities to individuals with cervical-level spinal cord injury through the use of an advanced wireless myoelectrically controlled battery-powered implanted neuroprosthetic system known as the "FIRSTHAND" System. This restored function can enable the individual to achieve greater independence in activities of daily living and an improved quality of life. Electrical stimulation of paralyzed muscles will be used to generate functional movements. The movements will be controlled using myoelectric signals generated from muscles under the subject's voluntary control. The specific hypotheses of this study are: 1) at least 75% of all subjects will be able to manipulate at least one more object in the Grasp-Release Test when using the advanced neuroprosthesis compared to without the neuroprosthesis. 2) At least 75% of all subjects will demonstrate an increased level of independence in at least one functional activity when using the advanced neuroprosthesis. 3) At least 75% of all subjects will demonstrate an average neuroprosthesis usage of at least three days/week.

Study Design

Study Type:
Interventional
Actual Enrollment :
10 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Hand Function for Tetraplegia Using a Wireless Neuroprosthesis
Actual Study Start Date :
Jan 1, 2012
Actual Primary Completion Date :
Nov 1, 2015
Actual Study Completion Date :
May 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Neuroprosthesis System

Receives implanted device for hand function.

Device: FIRSTHAND System
Implanted neuroprosthesis with myoelectric control and electrical stimulation of multiple channels.

Outcome Measures

Primary Outcome Measures

  1. Grasp Release Test - Test of Functional Ability to Pick up and Move Objects [6-9 weeks]

    Grasp and Release Test (GRT) - The Grasp and Release Test (GRT) [Wuolle, 1994; Smith et al., 1996; Carroll et al., 2000; Taylor et al., 2002; Mulcahey et al., 2004], developed at the Cleveland FES Center, has been utilized by multiple centers to show improvements in hand function after implantation of a neuroprosthesis and tendon transfers [Peckham, 2001]. This pick-and-place test requires the participant to unilaterally acquire, move, and release six objects varying in weight and size. The objects are: 1) a small peg, 2) a wooden cube, 3) a small juice can, 4) a videotape, 5) a paperweight (~1000g) and a simulated fork task (spring-loaded plunger). The number of objects that the participant can successfully manipulate are scored. Success in manipulating each object in the GRT is defined as the ability to pick up and place the object at least once within 30 seconds.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • cervical level spinal cord injury;

  • complete paralysis of fingers and thumbs;

  • voluntary shoulder motion;

  • electrically excitable forearm and hand musculature

Exclusion Criteria:
  • extreme contractures of the joints;

  • skeletal immaturity;

  • extensive denervation in the forearm and hand;

  • poor surgical risk

Contacts and Locations

Locations

Site City State Country Postal Code
1 Louis Stokes VA Medical Center, Cleveland, OH Cleveland Ohio United States 44106

Sponsors and Collaborators

  • VA Office of Research and Development

Investigators

  • Principal Investigator: Kevin L Kilgore, PhD, Louis Stokes VA Medical Center, Cleveland, OH

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

Responsible Party:
VA Office of Research and Development
ClinicalTrials.gov Identifier:
NCT00890916
Other Study ID Numbers:
  • A6027-R
First Posted:
Apr 30, 2009
Last Update Posted:
Jun 9, 2021
Last Verified:
May 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Keywords provided by VA Office of Research and Development
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail Note that the data from the first three (of 10) participants was published in the Journal of Hand Surgery (2008; 33(4):539-50).
Arm/Group Title Neuroprosthesis System
Arm/Group Description Subjects who have undergone implantation of the neuroprosthesis system known as the FIRSTHAND/IST-12 System.
Period Title: Rehab - Neuroprosthesis (NP) "On"
STARTED 10
Grasp Release Pre-Test "ON" 10
COMPLETED 10
NOT COMPLETED 0
Period Title: Rehab - Neuroprosthesis (NP) "On"
STARTED 10
Grasp Release Pre-Test "OFF" 10
COMPLETED 10
NOT COMPLETED 0

Baseline Characteristics

Arm/Group Title Neuroprosthesis System
Arm/Group Description Receives implanted device for hand function. FIRSTHAND System: Implanted neuroprosthesis with myoelectric control and electrical stimulation of multiple channels. Also known as the "IST-12" System.
Overall Participants 10
Age (Count of Participants)
<=18 years
0
0%
Between 18 and 65 years
10
100%
>=65 years
0
0%
Sex: Female, Male (Count of Participants)
Female
2
20%
Male
8
80%
Grasp-Release Test (Number of Completions) [Median (Full Range) ]
Median (Full Range) [Number of Completions]
2

Outcome Measures

1. Primary Outcome
Title Grasp Release Test - Test of Functional Ability to Pick up and Move Objects
Description Grasp and Release Test (GRT) - The Grasp and Release Test (GRT) [Wuolle, 1994; Smith et al., 1996; Carroll et al., 2000; Taylor et al., 2002; Mulcahey et al., 2004], developed at the Cleveland FES Center, has been utilized by multiple centers to show improvements in hand function after implantation of a neuroprosthesis and tendon transfers [Peckham, 2001]. This pick-and-place test requires the participant to unilaterally acquire, move, and release six objects varying in weight and size. The objects are: 1) a small peg, 2) a wooden cube, 3) a small juice can, 4) a videotape, 5) a paperweight (~1000g) and a simulated fork task (spring-loaded plunger). The number of objects that the participant can successfully manipulate are scored. Success in manipulating each object in the GRT is defined as the ability to pick up and place the object at least once within 30 seconds.
Time Frame 6-9 weeks

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title Neuroprosthesis System
Arm/Group Description Subjects with the implanted FIRSTHAND/IST-12 System.
Measure Participants 10
Rehab - NP "OFF"
2
Rehab - NP "ON"
5.5

Adverse Events

Time Frame
Adverse Event Reporting Description
Arm/Group Title Neuroprosthesis System
Arm/Group Description Receives implanted device for hand function. FIRSTHAND System: Implanted neuroprosthesis with myoelectric control and electrical stimulation of multiple channels.
All Cause Mortality
Neuroprosthesis System
Affected / at Risk (%) # Events
Total / (NaN)
Serious Adverse Events
Neuroprosthesis System
Affected / at Risk (%) # Events
Total 0/10 (0%)
Other (Not Including Serious) Adverse Events
Neuroprosthesis System
Affected / at Risk (%) # Events
Total 2/10 (20%)
Infections and infestations
Device Infection 2/10 (20%) 2

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

All Principal Investigators ARE employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Dr. Kevin Kilgore
Organization Louis Stokes Cleveland VAMC
Phone 216-9573657
Email klk4@case.edu
Responsible Party:
VA Office of Research and Development
ClinicalTrials.gov Identifier:
NCT00890916
Other Study ID Numbers:
  • A6027-R
First Posted:
Apr 30, 2009
Last Update Posted:
Jun 9, 2021
Last Verified:
May 1, 2021